📰 Abt News
Page 28 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
February 14, 2024
Bank Julius Baer & Co. Ltd Zurich cut its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 3.5% in the third quarter, HoldingsChannel reports. The fund owned 2,027,142 shares of the healthcare product maker’s stock after selling 74,414 shares during the period. Abbott Laboratories accounts for approximately 1.1% of Bank Julius Baer & Co. […]
February 11, 2024
Arcblock (ABT) traded down 4.8% against the US dollar during the one day period ending at 12:00 PM E.T. on February 11th. One Arcblock token can now be bought for approximately $1.08 or 0.00002246 BTC on major exchanges. Over the last week, Arcblock has traded 87.5% higher against the US dollar. Arcblock has a market […]
February 11, 2024
Investment House LLC lowered its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.7% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 26,829 shares of the healthcare product maker’s stock after selling 455 shares during the period. Investment House LLC’s holdings […]
February 11, 2024
Deutsche Bank AG reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 7.2% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,583,686 shares of the healthcare product maker’s stock after selling 432,200 shares during the quarter. Deutsche Bank […]
February 10, 2024
Boston Financial Mangement LLC boosted its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.3% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 65,627 shares of the healthcare product maker’s stock after purchasing an additional 171 shares during the quarter. […]
February 10, 2024
Prime Capital Investment Advisors LLC grew its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 11.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 71,339 shares of the healthcare product maker’s stock after purchasing an additional 7,273 shares during the […]
February 10, 2024
Skandinaviska Enskilda Banken AB publ decreased its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 6.3% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 352,920 shares of the healthcare product maker’s stock after selling 23,596 shares during the quarter. Skandinaviska Enskilda Banken AB […]
February 10, 2024
S&CO Inc. raised its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 266,531 shares of the healthcare product maker’s stock after purchasing an additional 230 shares during the quarter. Abbott […]
February 10, 2024
Homestead Advisers Corp cut its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 12.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,101,146 shares of the healthcare product maker’s stock after selling 151,089 shares during the quarter. Abbott Laboratories […]
February 9, 2024
Howe & Rusling Inc. decreased its position in Abbott Laboratories (NYSE:ABT – Free Report) by 2.2% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,839 shares of the healthcare product maker’s stock after selling 108 shares during the quarter. Howe & Rusling […]